HARTFORD MULTIFACTOR SMALL CAP ETF ROSC 深 沪
等待开盘 09-23 09:30:00 美东时间
43.7155
-0.476
-1.08%
华盛通- 最 高43.72
- 今 开43.72
- 成交量 353股
- 最 低 43.7155
- 昨 收 44.1915
- 总市值 4371.55万
- 52周最高 45.69
- 市盈率 静 --
- 换手率 0.04%
- 52周最低 33.5834
- 委 比 0.00%
- 总股本 100.00万
- 历史最高 45.69
- 量 比 0.76
- 振 幅 0.01%
- 历史最低 14.4832
- 每 手 1
- 风险率 2.58%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多scPharmaceuticals announces non-dilutive financing up to $125M with Perceptive Advisors
scPharmaceuticals (NASDAQ:SCPH) on Monday announced non-dilutive financings totaling up to $125M with funds managed by Perceptive Advisors. Proceeds from the transactions will be used to repay existin...
08-13 00:53
scPharmaceuticals Secures Funding, Advances FUROSCIX Commercialization
scPharmaceuticals (SCPH) has issued an update. scPharmaceuticals, Inc. secured ...
08-12 18:41
ScPharmaceuticals Sees Prelim. FY23 FUROSCIX Revenue $13.4M-$13.6M Vs $12.82M Est.
ScPharmaceuticals Sees Prelim. FY23 FUROSCIX Revenue $13.4M-$13.6M Vs $12.82M E...
01-05 05:09
scPharmaceuticals Announces Type C Meeting Feedback From FDA On Potential Heart Failure Class IV Indication Expansion
scPharmaceuticals Inc. (NASDAQ:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce
2023-08-01 20:13
ScPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BURLINGTON, Mass., July 19, 2023 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Na...
2023-07-19 20:00
